Document Detail


Microfluidic large-scale integration: the evolution of design rules for biological automation.
MedLine Citation:
PMID:  17269901     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Microfluidic large-scale integration (mLSI) refers to the development of microfluidic chips with thousands of integrated micromechanical valves and control components. This technology is utilized in many areas of biology and chemistry and is a candidate to replace today's conventional automation paradigm, which consists of fluid-handling robots. We review the basic development of mLSI and then discuss design principles of mLSI to assess the capabilities and limitations of the current state of the art and to facilitate the application of mLSI to areas of biology. Many design and practical issues, including economies of scale, parallelization strategies, multiplexing, and multistep biochemical processing, are discussed. Several microfluidic components used as building blocks to create effective, complex, and highly integrated microfluidic networks are also highlighted.
Authors:
Jessica Melin; Stephen R Quake
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  Annual review of biophysics and biomolecular structure     Volume:  36     ISSN:  1056-8700     ISO Abbreviation:  Annu Rev Biophys Biomol Struct     Publication Date:  2007  
Date Detail:
Created Date:  2007-05-04     Completed Date:  2007-08-09     Revised Date:  2007-12-03    
Medline Journal Info:
Nlm Unique ID:  9211097     Medline TA:  Annu Rev Biophys Biomol Struct     Country:  United States    
Other Details:
Languages:  eng     Pagination:  213-31     Citation Subset:  IM    
Affiliation:
Department of Bioengineering, Stanford University and Howard Hughes Medical Institute, Stanford, California 94305, USA. melin@stanford.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Automation
Biochemistry / methods
Biophysics / methods*
Cell Line
DNA, Complementary / metabolism
Dimethylpolysiloxanes / chemistry
Equipment Design
Humans
Mice
Microfluidic Analytical Techniques*
Microfluidics / methods*
Models, Biological
Models, Theoretical
RNA, Messenger / metabolism
Silicones / chemistry
Grant Support
ID/Acronym/Agency:
1R01 HG002644-01A1/HG/NHGRI NIH HHS
Chemical
Reg. No./Substance:
0/DNA, Complementary; 0/Dimethylpolysiloxanes; 0/RNA, Messenger; 0/Silicones; 63148-62-9/baysilon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A brief review of the pharmacologic and therapeutic aspects of memantine in Alzheimer's disease.
Next Document:  Predicting physical activity among low-income Mexican American women: application of the theory of p...